Which is one of the largest IPO opening this week?
- Answer Field
-
SBI Funds Management IPO is scheduled to open for public subscription on 14 July 2026 and remain open until 16 July 2026.
Manipal Health Enterprises Limited is an integrated healthcare provider operating a network of multispeciality hospitals with secondary, tertiary and quaternary care facilities in India. The organisation supplies services in the fields of cardiology, oncology, neurosciences, orthopaedics, organ transplantation, critical care, diagnostics, pharmacy and many other clinical specialities. Over the years, the company has expanded its hospital network through acquisitions and investments in healthcare infrastructure. It also has outpatient services, preventive health programmes and diagnostic solutions to support its main hospital services. India's healthcare sector continues to be supported by rising healthcare demand, increasing insurance penetration, advances in medical technology and greater health awareness.
Meanwhile, hospital operators are confronted by variables like regulatory changes, capital expenditure demands, integration of acquired businesses, availability of competent medical staff and operational hazards involved with healthcare delivery.
The healthcare services industry in India plays an important role in providing medical treatment across the country. Growing awareness about healthcare, longer life expectancy, higher insurance penetration and increasing demand for specialised treatments have aided the establishment of multi-speciality hospital networks. The Draft Red Herring Prospectus (DRHP) sector overview states that organised healthcare providers continue to invest in capacity development, technology adoption and clinical quality to address evolving patient needs.
Manipal Health Enterprises Limited filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) on March 23, 2026, for raising money through an Initial Public Offering (IPO). The company operates an integrated hospital network and offers secondary, tertiary and quaternary healthcare services across multiple specialities. It has grown organically and through acquisitions over the years to bolster its presence in many parts of the nation.
For investors seeking to understand the company’s operations, financial performance, industry position, and business risks, the DRHP provides insights into its business model and proposed utilisation of the IPO proceeds. This article simplifies the key information available in the DRHP in an easy-to-understand format.
The table below highlights the key details of the public issue available in the DRHP, while certain information such as the price band, lot size, and issue dates is yet to be announced.
Particulars | Details |
IPO Type | Book-Built Issue |
IPO Open Date | To be announced |
IPO Close Date | To be announced |
Face Value | ₹2 per equity share |
Price Band | To be announced |
Lot Size | To be announced |
Fresh Issue | Equity shares aggregating up to ₹8,000 crore |
Offer for Sale | Up to 4,32,27,668 equity shares |
Total Issue Size | Fresh Issue of up to ₹8,000 crore plus Offer for Sale of up to 4,32,27,668 equity shares |
Listing Exchange | NSE and BSE |
The IPO consists of both a Fresh Issue and an Offer for Sale (OFS).
Under the Fresh Issue portion, the company will receive the proceeds from the issue. The Offer for Sale comprises equity shares being sold by certain promoters and investor selling shareholders. The proceeds from the OFS will be received by the respective selling shareholders and not by the company.
The final issue size in rupee terms, price band, lot size, and subscription dates will be announced closer to the opening of the public issue.
Manipal Health Enterprises Limited was originally incorporated in February 2010 as Manipal Health Enterprises Private Limited. It was subsequently converted into a public limited company and renamed Manipal Health Enterprises Limited in December 2025.
The company’s promoters include Dr Ranjan Ramdas Pai; Manipal Global Health Services; MEMG International Ltd; Kangto Investments Pte. Ltd; Imperius Healthcare Investments Pte. Ltd; and Kabru Investments Pte. Ltd. The company has expanded its healthcare network through acquisitions and organic growth across multiple regions in India.
Manipal Health Enterprises is an integrated healthcare provider that operates a network of multi-speciality hospitals delivering secondary, tertiary, and quaternary care services.
Its healthcare offerings span numerous clinical specialities, including:
Cardiology and cardiac surgery
Oncology
Neurosciences
Orthopaedics
Organ transplantation
Gastroenterology
Nephrology
Critical care
Women and child care
Internal medicine and other speciality services
In addition to inpatient and outpatient care, the company provides diagnostics, pharmacy, preventive healthcare, and related medical services through its hospital ecosystem.
The group has expanded through acquisitions of established hospital chains and healthcare assets, broadening its geographic footprint and clinical capabilities.
Manipal Health Enterprises primarily generates revenue through the delivery of healthcare services.
Its principal revenue streams include:
Inpatient treatments
Outpatient consultations
Surgical procedures
Diagnostic services
Pharmacy sales
Health check programmes
Other hospital-related services
Revenue is generated from self-paying patients as well as those covered under insurance programmes, corporate arrangements, and government healthcare schemes.
Manipal Health Enterprises operates an integrated hospital network in India. Through its owned and operated hospitals, subsidiaries, and acquired healthcare businesses, the company has established a presence across several major cities and regions.
Its network includes hospitals operating under various healthcare brands, enabling it to provide multi-speciality and super-speciality medical services while serving patients with varying healthcare requirements.
India’s healthcare delivery sector has expanded significantly over the past decade, driven by rising income levels, increasing awareness of preventive healthcare, greater health insurance coverage, and growing demand for specialised medical treatment. Organised hospital chains have continued to invest in infrastructure, technology, and clinical capabilities to meet the evolving healthcare needs of patients.
India is one of the largest healthcare markets in the world, with demand driven by population growth, urbanisation, an ageing demographic and an increasing burden of chronic diseases, as per the industry overview section of the DRHP. Changes in patient care and hospital operations have also been driven by advances in medical technology and digital healthcare solutions.
The private healthcare sector plays an important role in delivering tertiary and quaternary medical services, particularly in areas such as oncology, organ transplantation, cardiology, neurosciences, and critical care. Hospital operators are also expanding into diagnostics, preventive healthcare, home healthcare, and digital services to provide integrated patient care.
Growing demand for quality healthcare services
Rising health insurance penetration
Increasing prevalence of lifestyle-related diseases
Expansion of multi-speciality and super-speciality hospitals
More investment in healthcare infrastructure
Usage of digital technologies and modern medical devices
Growth in preventive healthcare and diagnostics
As healthcare needs evolve, organised hospital networks continue to expand their clinical offerings and geographic presence to address growing demand for healthcare services.
The table below presents selected financial information from the restated consolidated financial statements disclosed in the DRHP. The table below summarises key financial metrics based on the restated consolidated financial statements disclosed in the DRHP.
Financials (₹ crore) | FY2025 | FY2024 | FY2023 |
Assets | 21,443.81 | 10,818.83 | 7,936.78 |
Total Income | 9,409.12 | 6,265.17 | 4,927.57 |
Profit After Tax | 534.80 | 533.20 | 414.20 |
EBITDA | 2,455.03 | 1,596.98 | 1,228.24 |
Net Worth | 5,865.66 | 4,029.22 | 3,325.29 |
The company has a wide network of hospitals in various cities of India and is engaged in providing secondary, tertiary and quaternary healthcare services through established healthcare facilities.
Manipal Health Enterprises offers treatment in several medical fields like cardiology, cancer, neurosciences, orthopaedics, gastroenterology, nephrology, transplant services and critical care. The company offers services across multiple clinical specialities.
Through acquisitions and organic expansion, the company operates hospitals under multiple healthcare brands across different regions of India.
The company has diversified its revenue sources, earning income from inpatient care, outpatient consultations, surgeries, diagnostics, pharmacy services, preventive healthcare programmes and related hospital services.
The company’s operations are supported by experienced leadership teams, doctors, nursing staff, and healthcare professionals involved in clinical delivery, hospital administration, and patient care.
The healthcare business is heavily regulated in terms of licensing, quality requirements, price and patient safety. Changes in regulations may impact operations.
Hospitals need a lot of investment in medical infrastructure, equipment, technology and facilities to develop and expand. Future capital requirements may continue to be significant.
The company’s capacity to attract and retain qualified doctors, specialists, nurses and healthcare personnel also has a significant impact on the quality of the services provided and the efficiency of operations.
The company has expanded through acquisitions of hospitals and healthcare businesses. Successfully integrating acquired entities remains important for operational performance.
Hospitals face risks associated with patient care, infection control, medical equipment, litigation, and compliance with healthcare standards and protocols.
The organised healthcare market includes several hospital operators competing for patients, medical talent, and expansion opportunities across different regions of India.
Before evaluating the IPO, investors may consider the following factors:
The company’s position as an integrated healthcare provider with operations across multiple regions in India.
Its network of multi-speciality hospitals and the range of medical services offered.
Revenue generated from inpatient care, outpatient services, diagnostics, pharmacy, and other healthcare offerings.
Historical financial performance and key metrics disclosed in the DRHP.
The proposed utilisation of the Fresh Issue proceeds, including repayment or prepayment of certain borrowings and general corporate purposes, as outlined in the DRHP.
The company’s expansion strategy through organic growth and acquisitions.
Demand trends in India’s healthcare services industry, including increasing healthcare expenditure and insurance penetration.
Risks associated with regulatory compliance, capital-intensive operations, integration of acquisitions, and dependence on skilled healthcare professionals.
The competitive landscape within the organised hospital sector and the company’s ability to maintain service quality and operational efficiency.
SBI Funds Management IPO is scheduled to open for public subscription on 14 July 2026 and remain open until 16 July 2026.
Yes. Zepto Limited has filed its Updated Draft Red Herring Prospectus (UDRHP) with SEBI and is awaiting further regulatory approvals.
NSE has filed its DRHP and is awaiting the necessary regulatory approvals before announcing its IPO.
Jio Platforms has filed its DRHP. The company is yet to announce the IPO dates and offer details.
Yes. Manipal Health Enterprises has filed its Draft Red Herring Prospectus (DRHP) and is awaiting further regulatory progress and the announcement of its public issue details.
Disclaimer :
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited
This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading